Risk factors
Elutia (ELUT) risk factors
Item 1A of every Elutia Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors68 risks11 new16 dropped17 reworded
Elutia sold its entire cardiac device business on October 1, 2025, shifting its future results to rely on Women's Health, NXT-41x, and Cardiovascular products. The company received Nasdaq deficiency notices regarding its minimum bid price below $1.00 and market value requirements.
Filed Mar 13, 2026 - FY2024 10-K risk factors73 risks
Elutia faces going concern doubts after posting a 2024 net loss of $53.9 million alongside $23.9 million in debt.
Filed Mar 11, 2025